By Dr Mihir Shanker, Radiation Oncologist, Icon Cancer CentreFor many men, a prostate cancer diagnosis raises understandable ...
Health Canada has granted a Notice of Compliance (NOC) for Enhertu® (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback